International Antifungal Industry Research Report 2016 & Forecast

Fungal infection is most common in those with weakened immune system or those who have foreign material, including medical devices in their body like an artificial joint or heart valve. Fungal infections are categorized under opportunistic and primary fungal infection. Opportunistic fungal infection targets weak immune patients and can be very aggressive, spreading quickly to other organs and often leading to death. While primary fungal infection can occur in people with a normal immune system. There are several types of antifungal medicines. They come in as creams, sprays, solutions, tablets designed to go into the vagina (pessaries), shampoos, medicines to take by mouth, and injections. Most work by damaging the cell wall of the fungus, which causes the fungal cell to die.

Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/140135 .

The US is the largest market of anti-fungal drugs. It has the presence of the leading companies who specialize in anti-fungal drugs. The key factors driving growth of the anti-fungal market include rise in incidences of fungal infections in immuno-compromised patients, increase in number of cancer patients, rise in incidences of fungal infections in people suffering from AIDS, increase in spending on medicines, rise in sale of prescription drugs and many more.

Purchase a copy of Global Antiemetics Market visit @ http://www.orbisresearch.com/contact/purchase/140135   For more information contact sales@orbisresearch.com      .

However, market growth is hindered by the factors such as harsh side effects of drugs, drug resistance, high cost of anti-fungal, and lack of new anti-fungal therapies. The major trends featuring the market include increase in development of new drugs, flourishing public-private partnership in pharmaceutical industry, and growing awareness.

The report offers an in-depth analysis of the “Global Anti-Fungal Market” with special focus on invasive anti-fungal segment. It covers the regional and global aspects of the market. The top notch players in the market exhibit a very close competition. The report profiles JNJ, Novartis, Pfizer, and Merck & Co.

Browse Complete Report @ http://www.orbisresearch.com/reports/index/global-antifungal-market-industry-analysis-and-outlook-2016-2020   .

Some points from TOC:

1. Market Overview
1.1 Fungal Infection
1.2 Types of Fungal Infection
1.3 Treatment (Antifungal)

2. Global Antifungal Market
2.1 Global Antifungal Market by Value
2.2 Global Antifungal Market Forecast by Value
2.5 Global Antifungal Market by Region

3. Global Invasive Antifungal Market
3.1 Global Invasive Anti-Fungal Market by Value
3.2 Global Invasive Anti-Fungal Market Forecast by Value
3.3 Global Invasive Anti-Fungal Market by Drug Class
3.4 Global Invasive Anti-Fungal Market by Major Drugs
3.5 Global Invasive Anti-Fungal Market by Target Patients
3.6 Global Invasive Anti-Fungal Market by Therapeutic Indication

For any enquires before buying, connect with us @ enquiry@orbisresearch.com

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No.: +1 (214) 884-6817; +9164101019

Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research

Follow us on Twitter: https://twitter.com/orbisresearch

Like us on Facebook: https://www.facebook.com/OrbisResearch